1. Which patients are candidates for Jorveza®?1
Which patients are candidates for Jorveza®?1
Jorveza® is approved to treat eosinophilic oesophagitis (EoE) in adults (patients 18 years old and above). This drug should only be prescribed by doctors experienced in diagnosing and treating EoE.
Special patient groups:
Patients with hepatic impairment or severe renal impairment should not be treated with Jorveza®. The safety and efficacy of Jorveza® in children and adolescents under 18 years of age has not been determined. No data are available.
Precautions for use:
Please consult the Jorveza® Product Information for information on the contraindications and precautions, warnings, drug interactions, effects on fertility, use in pregnancy or lactation, as well as a summary of reported adverse effects.
2. What is the recommended dose regimen for Jorveza®?1
The recommended daily dose for induction therapy is 2 mg budesonide taken as one 1 mg tablet in the morning and one 1 mg tablet in the evening. Induction therapy typically lasts 6 weeks. This treatment period may be extended to 12 weeks for patients with inadequate response.
The recommended daily dose for maintenance of remission is 1 mg budesonide as one 0.5 mg tablet in the morning and one 0.5 mg tablet in the evening, or 2 mg budesonide as one 1 mg tablet in the morning and one 1 mg tablet in the evening, depending on the individual clinical requirement of the patient.
*The maintenance dose of 1.0 mg Jorveza® twice daily is recommended for patients with a long standing disease history and/or high extent of oesophageal inflammation in their acute disease state1
3. How should Jorveza® (budesonide) be taken?1
 |
A. Finish your meal
B. Take Jorveza® |
 |
Jorveza® should be placed on the tip of the tongue and gently pressed against the roof of the mouth.
Jorveza® should not be chewed or swallowed undissolved as this will reduce its effectiveness. Some people may find the taste to be slightly bitter, but the bitter taste may go away after a few minutes. |
 |
Jorveza® usually dissolves within 2–5 minutes but it may take longer in some people. The dissolved material mixed with saliva should be swallowed little by little while this occurs. This ensures maximum uptake of the medication in the lining of the oesophagus where you need it. |
  |
Wait at least 30 minutes before:
• eating
• drinking
• performing oral hygiene
• using oral medications such as liquid sprays or chewable tablets
This is very important for the medication to be effective. |
Jorveza® Instructions for use video
PLEASE REVIEW PRODUCT INFORMATION BEFORE PRESCRIBING.
COPIES OF THE PRODUCT INFORMATION FOR JORVEZA® CAN BE REQUESTED BY CALLING DR FALK PHARMA AUSTRALIA PTY LTD ON 1800 DRFALK (1800 373 233), OR AT THERAPEUTIC GOODS ADMINISTRATION.
|
PBS Information: Authority required for the treatment of EoE.
Refer to the PBS Schedule for full authority information.
|
4. Reference
- Jorveza® Product Information.
